Background: Although the human adenovirus-36 (Ad-36) has been associated with obesity and related lipid disorders in the United States, this association has yet to be identified in other countries. Therefore, we tried to determine whether Ad-36 is associated with obesity or lipid disorders in Korean schoolchildren. Method: A total of 318 Korean schoolchildren aged 6-15 years, who participated in the Ewha Womans University Obesity Research Study, were selected for a community-based cohort study. Non-obese and obese were defined as body mass index (BMI) o85th and X95th percentiles of the Korean reference BMI-for-age curves, respectively, according to International Obesity Task Force definitions. The cutoff points for lipid disorders were modified from the age-modified standards of the National Cholesterol Education Program (NCEP)-Adult Treatment Panel (ATP) III metabolic syndrome criteria. The Ad-36 antibody was measured using a serum neutralization assay. Results: More obese participants than non-obese participants tested positive for the Ad-36 antibody (28.57 vs 13.56%, respectively; P ¼ 0.0174). Within the obese group, the participants who tested positive for the Ad-36 antibody had higher levels of triglycerides (TG) and total cholesterol than those who tested negative for the Ad-36 antibody (Po0.001). However, these associations were not present in the non-obese group. The unadjusted odds ratio (OR) for Ad-36 antibody positivity was greater in obese participants than non-obese participants (OR ¼ 2.550, 95% confidence interval (CI): 1.154-5.633). However, this OR seemed to be nonsignificant when age, sex and lipid variables were included in the analysis (OR ¼ 1.752, 95% CI: 0.763-4.020). The unadjusted OR for the elevated TG was significantly higher in participants who were Ad-36 antibody-positive than those who were Ad-36 antibody-negative (OR ¼ 2.511, 95% CI: 1.448-4.353). This trend remained constant even after adjustment for age, sex and obesity (OR ¼ 2.328, 95% CI: 1.296-4.181). Conclusion: Ad-36 seems to be strongly associated with lipid disorders in Korean schoolchildren regardless of obesity.
Introduction
Obesity in childhood and adolescence is considered a major public health problem in many countries. Obesity in childhood and adolescence causes chronic diseases such as type 2 diabetes, lipid disorders and metabolic syndrome in later years. 1 As obese children are more likely to be obese in adulthood and because childhood and adolescent obesity are associated with psychosocial conditions such as depression, it is more effective to start preventing weight gain among overweight children than among overweight adults. Therefore, risk factors associated with childhood and adolescent obesity should be assessed to prevent obesity-related diseases. Excess calorie intake and low level of physical activity have long been known as risk factors for obesity. In addition, in the last two decades, infectious agents such as viruses and bacteria have also been shown to cause obesity, a concept that is known as 'Infectobesity'. 2 Several of the infectious agents that have been shown to induce adipogenesis (obesity) or related lipid disorders in animal models are not human pathogens. 3 Recently,
Atkinson et al. 4 reported that obese adults in the United
States have a higher prevalence of serum antibodies against adenovirus-36 (Ad-36) (30%) compared with non-obese adults in the United States (11%). Although this result is compelling evidence for the 'Infectobesity' concept, ethnic groups other than Americans should be tested before the concept can be generalized. Interestingly, it was reported that Ad-36 has a minor role in obesity in the Danish population, as its prevalence is very low (5%). 2 Positivity of the Ad-36 antibody has also been associated with lower triglyceride (TG) and total cholesterol (TC) in chickens, mice and nonhuman primates. 5 Moreover, this association between Ad-36 infection and lipid disorders was also evident in a human adult sample in which the mean age was 35 years. However, the existence of such a relationship has yet to be examined in children and adolescents. Therefore, we conducted a trial to determine whether Ad-36 is associated with obesity or related lipid disorders among relatively homogeneous Korean children and adolescents. ). Non-obese and obese were defined as BMI o85th and X95th percentiles of the Korean reference BMI-for-age curves, respectively, according to International Obesity Task Force definitions as described earlier. 6 The cutoff points for lipid disorders were modified from age-modified standards of the National Cholesterol Education Program (NCEP)-Adult Treatment Panel (ATP) III metabolic syndrome criteria. 7 Three blood pressure readings were taken after a 10-min rest from the right arm of each subject at intervals of 5 min using an oscillometric device. The average of the three measurements was used for the analysis. Fat mass and fat percentages were assessed using a segmental bioelectrical impedance analyzer with eight tactile electrodes according to the manufacturer's instructions (J 10; Biospace, Seoul, Korea). Blood glucose was measured using the hexokinase method. Levels of TC, HDL-C (high-density lipoprotein cholesterol), low-density lipoprotein cholesterol (LDL-C) 8 and TG were measured using enzymatic colorimetry (ADVIA 1650; Bayer, Pittsburgh, PA, USA).
Methods

Study population
9
Detection of Ad-36 antibody in serum All procedures were described in an earlier report. 4 Human
Ad-36 from the American Type Culture Collection (Manassas, VA, USA) was grown on A549 cells, a human bronchial carcinoma tissue culture line. The tissue culture infectious dose 50 (TCID-50), the dose of virus that had a cell cytotoxic effect (CPE) in 50% of the wells, was determined using standard methods. 4, 10 Serum-neutralizing assays for Ad-36
antibodies in serum were performed using the constant virus-decreasing serum method. Serum samples that did not induce a CPE in dilutions of 1:8 or more were considered positive for the presence of neutralizing antibodies to Ad-36 and evidence of earlier infection with Ad-36. 4 Statistical analysis Data are expressed as the mean±s.d. or as number and percentage. Differences between non-obese and obese children and differences according to the presence of the Ad-36 antibody among non-obese and obese children were evaluated using the Wilcoxon rank-sum test or the w 2 -test (Fisher's exact test), as appropriate. Logistic regression analysis was conducted to determine the odds ratio (OR) for obesity and lipid disorders according to the presence of the Ad-36 antibody. Statistical analyses were performed using the SAS software (SAS 9.1; SAS Institute, Cary, NC, USA). Statistical significance was defined as Po0.05.
Results
Characteristics of study participants
We recruited 255 obese and 59 non-obese children and adolescents (Table 1 ). There were no significant differences in age and sex between the two groups. Obese individuals were significantly taller (P ¼ 0.0245) and heavier than nonobese individuals (Po0.0001). Significantly higher BMI, waist circumference, body fat, blood pressure, fasting glucose level and LDL-C level were also observed in obese participants compared with non-obese participants. Serum TG level was much higher in obese participants than in non-obese participants (Po0.0001). However, TC level did not differ between the groups. Interestingly, there was a significant difference in the percentages of participants that were Ad-36 antibody-positive between the two groups (P ¼ 0.0174): 28.57% of obese participants were Ad-36 antibody-positive compared with 13.56% of non-obese individuals.
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Characteristics of participants according to the Ad-36 antibody status
The characteristics of non-obese and obese participants according to the Ad-36 antibody status are shown in Table 2 . No significant differences in BMI according to the Ad-36 antibody status were observed among the non-obese children (P ¼ 0.5022) or obese participants (P ¼ 0.1170).
In the non-obese group, none of the variables differed according to the Ad-36 antibody status. In the obese group, however, participants who were Ad-36 antibody-positive had significantly higher levels of TG, TC and LDL-C than those who were Ad-36 antibody-negative.
ORs and 95% CIs for obesity according to the Ad-36 antibody status The results of logistic regression analysis are shown in 
Discussion
We observed a strong relationship between Ad-36 antibodypositive status and lipid disorders in Korean children and adolescents. Moreover, the percentage of Ad-36 antibodypositive participants was significantly higher in the obese group compared with the non-obese group. This association supports previous US data. 5 Obese participants who were
Ad-36 antibody-positive had higher TG and TC levels than those who were Ad-36 antibody-negative. After adjustment for age, sex and obesity, the risk for elevated TG (X110 mg per 100 ml) was found to be 4twofold greater for Ad-36 antibody-positive participants than Ad-36 antibody-negative subjects. This result suggests that the Ad-36 antibody may be an independent risk factor for elevated TG. As far as we are aware, this report is the first to show a strong relationship between Ad-36 antibody-positive status and lipid disorders in an ethnic group other than US participants. Furthermore, our results show that the association is valid for children and adolescents. An earlier US study showed that obese and non-obese human participants, who were Ad-36 antibody-positive, paradoxically had lower levels of TG and TC than those who were Ad-36 antibody-negative. 4 These associations were also observed in chickens, mice and nonhuman primates infected with Ad-36. 5 Although infection with Ad-36 reduces serum TG and TC levels in animal models, this causal effect in humans is not completely secure. Our study also showed an association between Ad-36 seropositivity and TG and TC, but levels of TG and TC were elevated in Ad-36 antibody-positive participants. At the present juncture, we find ourselves unable to provide an adequate answer to these seemingly incompatible findings. Several factors such as differences in race, age and ethnic-specific lifestyles and diet may explain the disparity between our results and those of the aforementioned reports. Infection with Borna disease virus, Canine distemper virus and Rous-associated virus type 7 was reported to induce obesity in rats, 11 mice, 12 and chickens, 13 respectively, all of which were associated with an increased TG level. Furthermore, several reports have shown that infection with another virus, namely the human immunodeficiency virus, is also associated with increased TG. 14, 15 Further study is warranted to explain the disparity between our results and those of the aforementioned reports. 
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In this study, the percentage of Ad-36 antibody-positive participants was significantly higher in the obese group compared with the non-obese group. Our finding is fairly consistent with results reported earlier. Atkinson et al. 4 showed that among adults from three US cities, 30% of the obese reported earlier were Ad-36 antibody-positive compared with 11% of participants. Although the prevalence of Ad-36 antibody positivity in obese individuals differed considerably among the three cities (20-58%), within-city analysis showed that it was significantly higher in obese participants than in corresponding non-obese participants. It is interesting that the percentages of Ad-36 antibody positivity in obese and non-obese participants were very similar in the US and Korean studies, although the two studies were conducted under different conditions. First, the Korean participants were all of Asian ancestry but the US study mostly involved participants with Caucasian and Black ancestry. Second, our study was conducted among children and adolescents aged 6-15 years, whereas the US study was conducted among adults (average age ¼ 40 years). Third, the studies employed different definitions of obesity because of differences in the age of the participants. Our study defined obesity as a BMI X95th percentile of the Korean reference BMI-for-age curves, whereas the US study defined obesity as a BMI X30. Owing to these differences, the two studies cannot be compared directly. An additional study with a larger sample size and different ethnic groups is needed.
We also conducted multiple logistic regression analysis to determine whether Ad-36 is an independent risk factor for obesity in Korean children and adolescents. Our data showed that the unadjusted OR for Ad-36 antibody positivity was twin study hypothesized that Ad-36 infection also increases adiposity in humans. 4 The loss of statistical significance when TG and TC were included in the multiple regression analysis suggests that Ad-36 infection induces obesity by modifying TG and TC levels in humans. Whether Ad-36 infection decreases or increases TG and TC level warrants further investigation. Our study has limitations. As our results were obtained using a cross-sectional design, we could not define the causal relationship between lipid disorders and Ad-36 infection. Another limitation is that we used a relatively small and limited sample consisting of children and adolescents. Nonetheless, as far as we know, this is the first study to show that Ad-36 infection is strongly associated with lipid disorders in humans, especially children and adolescents. A large-scale study incorporating various ethnic groups and age groups should be conducted to evaluate the relationship between Ad-36 infection and obesity or related disorders.
